Molecular Diagnostics
Novel Pancreatic Cancer Screening Test to Combine DNA and Microbiome Biomarkers for Early-Stage Detection
A first-in-class screening test based on novel microbiome markers is under development for pancreatic cancer, which has one of the highest mortality rates among all major cancers. More...11 May 2023
New Diagnostic Approach Combines DNA Testing With AI Analysis for Coronary Heart Disease Risk Assessment
A novel test merges epigenetics, genetics, high-throughput computing, and artificial intelligence to pinpoint individuals at risk for coronary heart disease, a critical factor in delivering cost-effective health care to adults. More...10 May 2023
AI-Powered Blood Test Enables Early Detection of Pancreatic Cancer in High-Risk Patients
A simple DNA-based blood test, designed for patients at high risk for pancreatic cancer, including those newly diagnosed with type 2 diabetes aged 50 and above, can identify pancreatic cancer in its earliest stages. More...10 May 2023
Breakthrough Microfluidic Device Could Revolutionize Diagnosis and Treatment of Cancer
A new European initiative seeks to advance microfluidic technology for isolating and cultivating circulating tumor cells, which could potentially predict cancer metastasis and direct treatment strategies. More...10 May 2023
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Chromogenic Culture System
InTray™ COLOREX™ ECC
POC Immunoassay Analyzer
Procise DX
In Other News
First Of Its Kind Urine Biomarker Methylation Test Predicts Bladder Cancer Recurrence
Cancer Stem Cell Test Improves Survival of Patients with Deadly Brain Tumor
World-First Smartphone-Powered 5 Marker Lipid Test Aids in Early Detection of Cardiovascular Diseases
Microarray-Based Test to Help Better Understand and Detect Complicated UTI Infections
Single Automated Analyzer to Bring Full Suite of Diagnostics to Wherever Patients Are
Glass Filters to Separate Tumor Cells in Blood Tests Can Speed Up Cancer Diagnosis
Genomic Urine Test Enables Non-Invasive Detection of Bladder and Other Urinary Tract Cancers
Rapid and Inexpensive Paper-Based Test Simultaneously Quantifies Multiple Cardiac Biomarkers
New Blood Test May Reduce Invasive Surgeries for Bladder Cancer
Novel Autoantibody against Septin-3 Discovered in Neurological Disease
MDx Platform Offers Largest Variety of Leukemia-Related Diagnostic Tests for Early Detection
Simple Paper Test Analyses Urine Samples for Early Cancer Diagnosis
Blood Tests Can Help Physicians Correctly Diagnose Alzheimer's In Low-Resource Environments
Portable UTI Testing Platform Brings Lab-Quality Molecular Diagnostics to Point-Of-Care Settings
Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents
Multi-Cancer Blood Test Leverages Machine Learning to Detect and Classify Underlying Disease
First-Ever Mpox Rapid Test Can Be Adapted for Other Emerging Diseases
Minimally Invasive Blood Test Detects Breast Cancer at Earlier Stages
Rapid Molecular Diagnostics Platform Uses Multiplex PCR Technology for Fast Diagnosis of Severe Infectious Diseases
Rapid Metagenomics Diagnoses Antibiotic Resistant Bloodstream Infections 18-42 Hours Faster Than Conventional Tests
30-Minute Molecular Assay to Revolutionize Tuberculosis Diagnosis within Near Patient Settings
Novel Reference Materials Meet Needs of Labs Testing for BRCA1/2 Gene Variants
Revolutionary Tests Powered by Exosome-Isolation Technology to Detect Challenging Cancers from Blood Draw
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
